CAPITAL STOCK (Details) - USD ($)				1 Months Ended	3 Months Ended	6 Months Ended
	Apr. 01, 2020	Dec. 17, 2019	Nov. 15, 2019	Dec. 31, 2018	Mar. 31, 2020	Mar. 31, 2020	Sep. 30, 2019
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Number of warrants outstanding					2,121,755	2,121,755	263,592
Offering
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Common stock issued in private placement, net of offering costs (in shares)		2,285,000	2,285,000
Number of common stock called by warrants		2,627,750	2,285,000
Number of common shares that each warrant has right to purchase			1
Public offering price for each share together with warrant			$ 5.25
Exercise price of warrants (in dollars per share)			$ 5.25	$ 5.60
Additional number of common stock called by warrants		342,750	342,750
Warrants exercisable expiration period			45 days
Gross proceeds of offering before underwriter discounts, commissions and other offering expenses		$ 12,000,000	$ 12,000,000
Amount of common shares issued under underwriters partial exercise of over-allotment option		$ 3,428
Net proceeds from offering after deducting underwriting fees and other expense			$ 10,500,000
Minimum exercise price			$ 1.47
Beneficial Ownership Limitation (as a percent)			4.99%
Beneficial Ownership Limitation, at the election of the holder (as a percent)			9.99%
Prior notice period to increase beneficial ownership			61 days
Number of warrants outstanding				8,375
Incremental change in fair value of warrants				$ 2,842
Number of warrants exercised					566,950	566,950
Proceeds from exercise of warrants					$ 2,770,000	$ 2,770,000
Offering | Subsequent event
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Number of warrants exercised	596,400
Proceeds from exercise of warrants	$ 2,910,000